No plans to scale back in Japan as AstraZeneca looks to "good quality" growth
20 October 2011
Ian Haydock
Please Login to read the full article.
20 October 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- AstraZeneca boosts oncology portfolio in Japan with Daiichi denosumab deal
- AstraZeneca tries to plug development gap with two Asian deals
- Mirabegron approved in first market as Gardasil and Rotarix also get formal Japanese nod
- Daiichi Sankyo drops ghrelin candidate, sees US olmesartan weakness this year
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
